<DOC>
	<DOCNO>NCT00681785</DOCNO>
	<brief_summary>The rationale thrombophrophylaxis well know . Without prophylaxis incidence objectivlely confirm , hospital-acquired deep venous thrombosis approximately 10 % 40 % among medical general surgical patient . In urology prevalence 15-40 % . The Seventh ACCP Conference Antithrombotic Thrombolytic Therapy1 recommend specific prophylaxis patient undergoing transurethral procedure . Our study first double-blind , placebo-controlled study Dalteparine thrombophrophylaxis transurethral surgery . The aim study proof thrombophrophylaxis cause complication transurethral surgery without .</brief_summary>
	<brief_title>Thrombophylaxis Transurethral Surgery With Dalteparine</brief_title>
	<detailed_description>The aim study proof transurethral surgery thrombophylaxis dalteparine safe . The study design double-blind placebo control .</detailed_description>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<criteria>transurethral surgery oral anticoagulation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>thrombophylaxis transurethral surgery</keyword>
</DOC>